Jack Bailey, President of GlaxoSmithKline Plc’s U.S. Pharmaceuticals, is working on bringing new drugs to market as efficiently as possible and says the days of unfettered pricing are done. Read more here. (Source: Cynthia Koons, Bloomberg Business, 2/11/16)